• Leo International Precision Health is implementing a bonus share issue, issuing 184 additional shares for each existing share.
• Shareholders will hold 185 shares for every share previously owned, with no change to overall equity or ownership percentages.
• Share capital rises to EUR 106.56 million via conversion of EUR 105.98 million from capital reserves, with no new funds raised.
• Frankfurt-listed shares have traded ex-bonus shares since Oct. 12, 2026; the last pre-adjustment trading day was Oct. 9.
• New shares are entitled to profit participation from Jan. 1, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Leo International Precision Health AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610130155OMX_____CNEWS_DE_GNW1001277631_de) on October 13, 2026, and is solely responsible for the information contained therein.